San Francisco, CA · Founded 2006 · Privately Held (backing)
Developer of novel biologics designed to provide meaningful therapeutic benefits to patients. Omniox is based in San Francisco, CA and was founded in 2006. It was valued at $150 million at its later-stage round in Nov 2023, the last priced event on record. It has raised $120 million across 5 recorded rounds; the latest was a $24.1 million debt round in Aug 2016.
PMV mark · valuation
$150.0M
Oct 2026
Priced at
its later-stage round
Nov 2023
Total raised
$119.7M
Last round
Debt
Aug 2016
No prints on record
No secondary trades in Omniox shares have been recorded yet. When market activity lands it appears here as monthly aggregates and, for platform-recorded trades, dated prints.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Omniox with a free account
·The complete investor list: 18 names
·Watch Omniox: the Monday email on marks, rounds and moves
Secondary marks are indicative month-end price levels observed across secondary-market trading venues — a level, not a trade — and are the market input to the PrivateMarketView mark. Private share prices aren’t published anywhere. Aggregate figures combine multiple reporting channels — direct participant reports, platform transactions, third-party market intelligence — at monthly granularity. Individually dated prints are a Pro feature and are shown only for transactions recorded on our own platform. Third-party-reported trades are never republished individually, at any tier. Verified prints (✓) have been confirmed against a second source. Prints marked SPV or Forward reflect the structure’s pricing, which can differ from direct share transfers of Omniox stock.
